{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:01:10Z","timestamp":1791928870427,"version":"4.3.4"},"reference-count":60,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"12","license":[{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2024,10,9]]},"DOI":"10.1167\/iovs.65.12.14","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T11:31:16Z","timestamp":1728473476000},"page":"14","source":"Crossref","is-referenced-by-count":13,"title":["Comprehensive Pharmacokinetic Evaluation of High Melanin Binder Levofloxacin in Rabbits Shows Potential of Topical Eye Drops for Posterior Segment Treatment"],"prefix":"10.1167","volume":"65","author":[{"given":"Sina","family":"Bahrpeyma","sequence":"first","affiliation":[{"name":"School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland"},{"name":"Faculty of Pharmacy, University of Helsinki, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Jakubiak","sequence":"additional","affiliation":[{"name":"Roche Pharma Research and Early Development, F. Hoffmann-La Roche, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n","family":"Alvarez-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Roche Pharma Research and Early Development, F. Hoffmann-La Roche, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"Caruso","sequence":"additional","affiliation":[{"name":"Roche Pharma Research and Early Development, F. Hoffmann-La Roche, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Leuthardt","sequence":"additional","affiliation":[{"name":"Roche Pharma Research and Early Development, F. Hoffmann-La Roche, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Senn","sequence":"additional","affiliation":[{"name":"Roche Pharma Research and Early Development, F. Hoffmann-La Roche, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"del Amo","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arto","family":"Urtti","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland"},{"name":"Faculty of Pharmacy, University of Helsinki, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"11","key":"bib1","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"issue":"2","key":"bib2","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"1","key":"bib3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1089\/jop.2007.0043","article-title":"Preservative-free triamcinolone acetonide suspension developed for intravitreal injection","volume":"24","author":"Bitter","year":"2008","journal-title":"J Ocul Pharmacol Ther"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12348-019-0189-4","article-title":"Ozurdex (dexamethasone intravitreal implant) for the treatment of intermediate, posterior, and panuveitis: a systematic review of the current evidence","volume":"10","author":"Saincher","year":"2020","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"25158414211027708","DOI":"10.1177\/25158414211027708","article-title":"KSI-301: antibody biopolymer conjugate in retinal disorders","volume":"13","author":"Chandrasekaran","year":"2021","journal-title":"Ther Adv Ophthalmol"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ejpb.2015.01.003","article-title":"Intravitreal clearance and volume of distribution of compounds in rabbits: in silico prediction and pharmacokinetic simulations for drug development","volume":"95","author":"del Amo","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"bib8","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ophtha.2014.09.036","article-title":"Clinical evaluation of pazopanib eye drops versus ranibizumab intravitreal injections in subjects with neovascular age-related macular degeneration","volume":"122","author":"Csaky","year":"2015","journal-title":"Ophthalmology"},{"issue":"3\u20134","key":"bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drudis.2007.11.002","article-title":"Current and future ophthalmic drug delivery systems: a shift to the posterior segment","volume":"13","author":"Del Amo","year":"2008","journal-title":"Drug Discov Today"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"105553","DOI":"10.1016\/j.ejps.2020.105553","article-title":"Topical ocular pharmacokinetics and bioavailability for a cocktail of atenolol, timolol and betaxolol in rabbits","volume":"155","author":"Fayyaz","year":"2020","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"bib11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.xphs.2020.09.051","article-title":"Comprehensive ocular and systemic pharmacokinetics of brinzolamide in rabbits after intracameral, topical, and intravenous administration","volume":"110","author":"Naageshwaran","year":"2021","journal-title":"J Pharm Sci"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"121515","DOI":"10.1016\/j.ijpharm.2022.121515","article-title":"Topical pharmacokinetics of dexamethasone suspensions in the rabbit eye: bioavailability comparison","volume":"615","author":"Naageshwaran","year":"2022","journal-title":"Int J Pharm"},{"issue":"12","key":"bib13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s11095-018-2519-x","article-title":"Topical drug delivery to the posterior segment of the eye: addressing the challenge of preclinical to clinical translation","volume":"35","author":"Rodrigues","year":"2018","journal-title":"Pharm Res"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"954771","DOI":"10.3389\/fddev.2022.954771","article-title":"Topical ophthalmic administration: can a drug instilled onto the ocular surface exert an effect at the back of the eye?","volume":"2","author":"del Amo","year":"2022","journal-title":"Front Drug Deliv"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.addr.2017.12.008","article-title":"Implications of melanin binding in ocular drug delivery","volume":"126","author":"Rimpel\u00e4","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"bib16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ijpharm.2017.04.010","article-title":"Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye","volume":"531","author":"Loftsson","year":"2017","journal-title":"Int J Pharm"},{"issue":"11","key":"bib18","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.cmi.2019.01.017","article-title":"Revisiting systemic treatment of bacterial endophthalmitis: a review of intravitreal penetration of systemic antibiotics","volume":"25","author":"Brockhaus","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"Del Amo","year":"2017","journal-title":"Prog Retin Eye Res"},{"issue":"9","key":"bib20","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1021\/acs.molpharmaceut.5b00729","article-title":"Prediction of ocular drug distribution from systemic blood circulation","volume":"13","author":"Vellonen","year":"2016","journal-title":"Mol Pharm"},{"issue":"1","key":"bib21","doi-asserted-by":"publisher","first-page":"e000557","DOI":"10.1136\/bmjresp-2020-000557","article-title":"Side effects of acetazolamide: a systematic review and meta-analysis assessing overall risk and dose dependence","volume":"7","author":"Schmickl","year":"2020","journal-title":"BMJ Open Respir Res"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2023.07.028","article-title":"Selective drug delivery to the retinal cells: biological barriers and avenues","volume":"361","author":"Ramsay","year":"2023","journal-title":"J Control Release"},{"issue":"22","key":"bib23","doi-asserted-by":"publisher","first-page":"10106","DOI":"10.1021\/acs.jmedchem.8b01281","article-title":"Understanding molecular drivers of melanin binding to support rational design of small molecule ophthalmic drugs","volume":"61","author":"Jakubiak","year":"2018","journal-title":"J Med Chem"},{"issue":"suppl 2","key":"bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0773.1972.tb03310.x","article-title":"The melanin affinity of chloroquine and chlorpromazine studied by whole body autoradiography","volume":"2","author":"Lindquist","year":"1972","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"issue":"2","key":"bib25","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1167\/iovs.12-10169","article-title":"Assessing a novel depot delivery strategy for noninvasive administration of VEGF\/PDGF RTK inhibitors for ocular neovascular disease","volume":"54","author":"Robbie","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"bib26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1089\/jop.1994.10.217","article-title":"Relevance of drug-melanin interactions to ocular pharmacology and toxicology","volume":"10","author":"Salazar-Bookman","year":"1994","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"bib27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0014-4835(84)90104-0","article-title":"Disposition of ophthalmic timolol in treated and untreated rabbit eyes. A multiple and single dose study","volume":"38","author":"Salminen","year":"1984","journal-title":"Exp Eye Res"},{"issue":"1\u20132","key":"bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0378-5173(84)90103-0","article-title":"Effect of ocular pigmentation on pilocarpine pharmacology in the rabbit eye. I. Drag distribution and metabolism","volume":"18","author":"Salminen","year":"1984","journal-title":"Int J Pharm"},{"issue":"1","key":"bib29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0378-5173(84)90132-7","article-title":"Effect of ocular pigmentation on pilocarpine pharmacology in the rabbit eye. II. Drug response","volume":"19","author":"Urtti","year":"1984","journal-title":"Int J Pharm"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tox.2013.03.012","article-title":"Chloroquine causes similar electroretinogram modifications, neuronal phospholipidosis and marked impairment of synaptic vesicle transport in albino and pigmented rats","volume":"308","author":"Lezmi","year":"2013","journal-title":"Toxicology"},{"issue":"9","key":"bib31","first-page":"1875","article-title":"Ocular pigmentation protects the rabbit retina from gentamicin-induced toxicity","volume":"36","author":"Zemel","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"bib32","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1006\/rtph.1998.1243","article-title":"Binding of drugs to eye melanin is not predictive of ocular toxicity","volume":"28","author":"Leblanc","year":"1998","journal-title":"Regul Toxicol Pharmacol"},{"issue":"8","key":"bib33","first-page":"671","article-title":"An explanation for the long duration of mydriatic effect of atropine in eye","volume":"15","author":"Salazar","year":"1976","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.jconrel.2022.05.059","article-title":"Mechanisms of cellular retention of melanin bound drugs: experiments and computational modeling","volume":"348","author":"Bahrpeyma","year":"2022","journal-title":"J Control Release"},{"issue":"9","key":"bib35","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1021\/acs.molpharmaceut.5b00787","article-title":"Drug distribution to retinal pigment epithelium: studies on melanin binding, cellular kinetics, and single photon emission computed tomography\/computed tomography imaging","volume":"13","author":"Rimpel\u00e4","year":"2016","journal-title":"Mol Pharm"},{"issue":"4","key":"bib36","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1124\/dmd.30.4.421","article-title":"Distribution of brimonidine into anterior and posterior tissues of monkey, rabbit, and rat eyes","volume":"30","author":"Acheampong","year":"2002","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"bib37","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1211\/0022357043932","article-title":"Comparative assessment of ocular tissue distribution of drug-related radioactivity after chronic oral administration of 14C-levofloxacin and 14C-chloroquine in pigmented rats","volume":"56","author":"Tanaka","year":"2010","journal-title":"J Pharm Pharmacol"},{"issue":"10","key":"bib38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/tvst.11.10.37","article-title":"Danicopan, an oral complement factor D inhibitor, exhibits high and sustained exposure in ocular tissues in preclinical studies","volume":"11","author":"Boyer","year":"2022","journal-title":"Transl Vis Sci Technol"},{"issue":"6","key":"bib39","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3390\/pharmaceutics12060554","article-title":"Microscale thermophoresis as a screening tool to predict melanin binding of drugs","volume":"12","author":"Hellinen","year":"2020","journal-title":"Pharmaceutics"},{"issue":"12","key":"bib40","doi-asserted-by":"publisher","first-page":"4890","DOI":"10.1021\/acs.molpharmaceut.9b00769","article-title":"Establishment of an in vitro-in vivo correlation for melanin binding and the extension of the ocular half-life of small-molecule drugs","volume":"16","author":"Jakubiak","year":"2019","journal-title":"Mol Pharm"},{"issue":"15","key":"bib41","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.4155\/bio-2018-0078","article-title":"Utilization of data below the analytical limit of quantitation in pharmacokinetic analysis and modeling: promoting interdisciplinary debate","volume":"10","author":"Hecht","year":"2018","journal-title":"Bioanalysis"},{"issue":"9","key":"bib42","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1007\/s11095-012-0805-6","article-title":"Use of pharmacokinetic data below lower limit of quantitation values","volume":"29","author":"Jusko","year":"2012","journal-title":"Pharm Res"},{"issue":"2","key":"bib43","doi-asserted-by":"publisher","first-page":"e00131","DOI":"10.1002\/prp2.131","article-title":"Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses","volume":"3","author":"Keizer","year":"2015","journal-title":"Pharmacol Res Perspect"},{"issue":"4","key":"bib44","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1097\/IJG.0000000000000185","article-title":"Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient","volume":"24","author":"Hu","year":"2015","journal-title":"J Glaucoma"},{"issue":"4","key":"bib45","doi-asserted-by":"publisher","first-page":"180","DOI":"10.5694\/mja2.50020","article-title":"Current management of glaucoma","volume":"210","author":"Lusthaus","year":"2019","journal-title":"Med J Aust"},{"issue":"7","key":"bib46","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/bjo.66.7.464","article-title":"Glaucoma patients not compliant with their drug therapy: clinical and behavioural aspects","volume":"66","author":"Granstr\u00f6m","year":"1982","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"bib47","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/eye.2000.197","article-title":"Compliance and viewpoint of glaucoma patients in Greece","volume":"14","author":"Konstas","year":"2000","journal-title":"Eye (Lond)"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.pharep.2014.12.013","article-title":"The pharmacokinetic interaction between levofloxacin and sunitinib","volume":"67","author":"Czyrski","year":"2015","journal-title":"Pharmacol Rep"},{"issue":"5","key":"bib49","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/jac\/47.5.611","article-title":"Cerebrospinal fluid penetration and pharmacokinetics of levofloxacin in an experimental rabbit meningitis model","volume":"47","author":"Destache","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"bib50","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.4142\/jvs.2020.21.e32","article-title":"Pharmacokinetic profiles of levofloxacin after intravenous, intramuscular and subcutaneous administration to rabbits (Oryctolagus cuniculus)","volume":"21","author":"Sitovs","year":"2020","journal-title":"J Vet Sci"},{"issue":"6","key":"bib51","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1021\/acs.molpharmaceut.8b00038","article-title":"Binding of small molecule drugs to porcine vitreous humor","volume":"15","author":"Rimpel\u00e4","year":"2018","journal-title":"Mol Pharm"},{"issue":"5","key":"bib52","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1080\/02713683.2016.1238941","article-title":"The relationship of brimonidine concentration in vitreous body to the free concentration in retina\/choroid following topical administration in pigmented rabbits","volume":"42","author":"Shinno","year":"2017","journal-title":"Curr Eye Res"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.exer.2015.05.003","article-title":"Rabbit as an animal model for intravitreal pharmacokinetics: clinical predictability and quality of the published data","volume":"137","author":"Del Amo","year":"2015","journal-title":"Exp Eye Res"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"109638","DOI":"10.1016\/j.exer.2023.109638","article-title":"Quantitative intravitreal pharmacokinetics in mouse as a step towards inter-species translation","volume":"235","author":"Puranen","year":"2023","journal-title":"Exp Eye Res"},{"issue":"1","key":"bib55","doi-asserted-by":"publisher","first-page":"10560","DOI":"10.1038\/s41598-019-47062-2","article-title":"High-resolution multimodal photoacoustic microscopy and optical coherence tomography image-guided laser induced branch retinal vein occlusion in living rabbits","volume":"9","author":"Nguyen","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"bib56","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.exer.2012.03.004","article-title":"Intraocular distribution of melanin in human, monkey, rabbit, minipig and dog eyes","volume":"98","author":"Durairaj","year":"2012","journal-title":"Exp Eye Res"},{"issue":"1","key":"bib57","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1089\/jop.1992.8.35","article-title":"Quantitative determination of the melanin contents in ocular tissues from human blue and brown eyes","volume":"8","author":"Menon","year":"1992","journal-title":"J Ocul Pharmacol Ther"},{"key":"bib58","doi-asserted-by":"publisher","first-page":"xli","DOI":"10.1016\/j.ajo.2017.12.019","article-title":"Evolution of intravitreal therapy for retinal diseases\u2014from CMV to CNV: the LXXIV Edward Jackson Memorial Lecture","volume":"191","author":"Martin","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"bib59","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Ghasemi Falavarjani","year":"2013","journal-title":"Eye (Lond)"},{"issue":"1","key":"bib60","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4103\/2320-3897.174429","article-title":"Intravitreal injections: a review of pharmacological agents and techniques","volume":"4","author":"Shikari","year":"2016","journal-title":"J Clin Ophthalmol Res"},{"key":"bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-3-642-69222-2_2","article-title":"Ocular pharmacokinetics","volume-title":"Pharmacology of the Eye","author":"Maurice","year":"1984"},{"key":"bib17","volume-title":"Endophthalmitis [Internet]","author":"Simakurthy","year":"2023"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2802109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:47Z","timestamp":1791927107000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2802109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":60,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.65.12.14","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,9]]}}}